Gross Jane A Insider Trades

Insider Trading History

Track insider trading activity for Gross Jane A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $25.7k 50,000 shares
Last Trade
May 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 50,000 shares
$0.95
$0.51
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $25.7k 50,000 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 50,000 shares
$3.34
$0.51
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $5k 9,750 shares
Last Trade
Mar 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15k 3,750 shares
$4.00
$0.51
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $412k 24,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.6k 24,000 shares
$1.86
$17.18
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $206k 12,000 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.2k 12,000 shares
$2.52
$17.18
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $103k 6,000 shares
Last Trade
Apr 26, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.1k 6,000 shares
$2.02
$17.18
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $0 0 shares
Last Trade
Apr 26, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.1k 6,000 shares
$2.02
$17.18
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2022 Sale
$4.81M 50,000 shares
$96.15
$3.26
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $103k 6,000 shares
Last Trade
Apr 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.6k 6,000 shares
$4.26
$17.18
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $0 0 shares
Last Trade
Nov 01, 2021 Sale
$1.21M 10,000 shares
$120.60
$3.26
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $24.5k 1,428 shares
Last Trade
Apr 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.01k 1,428 shares
$4.21
$17.18
Aptevo Therapeutics
Aptevo Therapeutics APVO
SVP & Chief Scientific Officer
Holding Value $82.2k 16,500 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24B 22,000 shares
$1,090,760.00
$4.98
Aptevo Therapeutics
Aptevo Therapeutics APVO
SVP & Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jul 27, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.47B 23,201 shares
$278,713.60
$4.98
Aptevo Therapeutics
Aptevo Therapeutics APVO
SVP & Chief Scientific Officer
Holding Value $38.8k 7,784 shares
Last Trade
Jul 27, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77B 9,924 shares
$278,713.60
$4.98
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $24.5k 1,428 shares
Last Trade
May 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.21k 1,428 shares
$3.65
$17.18
Aptevo Therapeutics
Aptevo Therapeutics APVO
SVP & Chief Scientific Officer
Holding Value $671k 134,800 shares
Last Trade
Feb 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.6B 134,800 shares
$227,008.40
$4.98
Aptevo Therapeutics
Aptevo Therapeutics APVO
See Remarks
Holding Value $612k 122,982 shares
Last Trade
Nov 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.3B 122,982 shares
$262,563.80
$4.98
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $39.3k 2,285 shares
Last Trade
Jun 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.7k 2,285 shares
$5.13
$17.18
Aptevo Therapeutics
Aptevo Therapeutics APVO
See Remarks
Holding Value $546k 109,583 shares
Last Trade
Mar 01, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.94B 2,710 shares
$715,668.80
$4.98
Aptevo Therapeutics
Aptevo Therapeutics APVO
See Remarks
Holding Value $559k 112,293 shares
Last Trade
Mar 01, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.54B 9,138 shares
$715,668.80
$4.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up